There have been significant updates to several sections of the SPC, including the following:

Change to section 4.4 - Special warnings and precautions for Use

Angioedema, including swelling of the larynx and glottis, causing airway obstruction and/or swelling of the face, lips, pharynx, and/or tongue has been reported in patients treated with valsartan; some of these patients previously experienced angioedema with other drugs including ACE inhibitors. Diovan should be immediately discontinued in patients who develop angioedema, and Diovan should not be re-administered.

Please refer to SPC link below for full information on all changes.